FDA.reportPublic FDA data

24 HR amphetamine 9.4 MG Extended Release Oral Tablet [Adzenys]

RxCUI
1739839
RxNorm name
24 HR amphetamine 9.4 MG Extended Release Oral Tablet [Adzenys]
Display name
24 HR amphetamine 9.4 MG Extended Release Oral Tablet [Adzenys]
Full name
24 HR amphetamine 9.4 MG Extended Release Oral Tablet [Adzenys]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c1179269-00b5-48ea-972d-31e614e99b7eAdzenys XR-ODT 9.4 MG 24HR Extended Release Distintegrating Oral Tablet [PSN] · 24 HR amphetamine 9.4 MG Extended Release Oral Tablet [Adzenys] [SBD] · Adzenys 9.4 MG 24 HR Extended Release Distintegrating Oral Tablet [SY]315These highlights do not include all the information needed to use ADZENYS XR-ODT™ safely and effectively. See full prescribing information for ADZENYS XR-ODT. ADZENYS XR-ODT (amphetamine) extended-release orally disintegrating tablets, CII Initial U.S. Approval: 196020260506